Sarepta Therapeutics, Inc. (SRPT)
21.31
+0.28
(+1.33%)
USD |
NASDAQ |
Sep 01, 16:00
21.31
0.00 (0.00%)
After-Hours: 16:32
Sarepta Therapeutics Total Long Term Debt (Quarterly) : 1.046B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.046B |
| March 31, 2026 | 1.037B |
| December 31, 2025 | 1.028B |
| September 30, 2025 | 1.250B |
| June 30, 2025 | 1.354B |
| March 31, 2025 | 1.344B |
| December 31, 2024 | 1.330B |
| September 30, 2024 | 1.398B |
| June 30, 2024 | 1.370B |
| March 31, 2024 | 1.379B |
| December 31, 2023 | 1.379B |
| September 30, 2023 | 1.372B |
| June 30, 2023 | 1.365B |
| March 31, 2023 | 1.288B |
| December 31, 2022 | 1.602B |
| September 30, 2022 | 1.578B |
| June 30, 2022 | 1.140B |
| March 31, 2022 | 1.137B |
| December 31, 2021 | 1.138B |
| September 30, 2021 | 1.158B |
| June 30, 2021 | 1.158B |
| March 31, 2021 | 1.152B |
| December 31, 2020 | 1.073B |
| September 30, 2020 | 768.70M |
| June 30, 2020 | 766.56M |
| Date | Value |
|---|---|
| March 31, 2020 | 753.22M |
| December 31, 2019 | 729.62M |
| September 30, 2019 | 486.16M |
| June 30, 2019 | 481.25M |
| March 31, 2019 | 477.92M |
| December 31, 2018 | 420.55M |
| September 30, 2018 | 415.45M |
| June 30, 2018 | 439.44M |
| March 31, 2018 | 430.81M |
| December 31, 2017 | 431.05M |
| September 30, 2017 | 31.28M |
| June 30, 2017 | 11.22M |
| March 31, 2017 | 13.69M |
| December 31, 2016 | 16.15M |
| September 30, 2016 | 18.60M |
| June 30, 2016 | 20.22M |
| March 31, 2016 | 20.98M |
| December 31, 2015 | 23.40M |
| September 30, 2015 | 23.29M |
| June 30, 2015 | 25.66M |
| March 31, 2015 | 6.38M |
| December 31, 2014 | 6.328M |
| September 30, 2014 | 6.275M |
| June 30, 2014 | 1.621M |
| March 31, 2014 | 1.645M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Moderna, Inc. | 1.266B |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| ImmunityBio, Inc. | 1.221B |
| X4 Pharmaceuticals, Inc. | 76.76M |
| MapLight Therapeutics, Inc. | 0.755M |